DESCRIPTION
Everotas 5mg belongs to the anti-neoplastic agent; it comes under mTOR kinase inhibitor (single transduction inhibitor). Everotas 5mg is an immunosuppressive macrolide.USED FOR
Breast cancerThe patient who fails to respond to the tablet letrozole or anastrozole therapy would be treated with Everotas. Everotas 5mg is used in an advanced stage of breast cancer.
Neuroendocrine tumors
Everotas 5mg involved in the treatment of some neuroendocrine tumors like pancreatic, gastrointestinal or lung cancer.
Renal cell cancer
Patient treating with Everotas 5mg after the failure of treatment with Sunitinib or Sorafenib.
Everotas 5mg also used in the condition of; Heart, liver, kidney transplantation
Waldenström macroglobulinemia
Other carcinoid tumors.
MECHANISM OF ACTION
Everotas is the prohibition of mammalian target of rapamycin (mTOR), a serine-threonine kinase.Everotas bind with intercellular protein (FKBP-12), leads to inhibitory complex formation with mTOR complex 1 (mTORC1) this leads to inhibition of mTOR kinase activity.
Everotas decreased the effect of S6 ribosomal protein kinase (S6K1) and eukaryotic elongation factor 4E binding protein (4E-BP1) which are essential for protein synthesis.
DOSAGE AND ADMINISTRATION
The recommended dose of the Tablet Everotas is 10mg should be taken as a single dose in all carcinogenic condition, except organ transplantation.Organ transplant: 0.75mg orally twice daily.
Brain/intracranial tumor: 4.5mg/m2 orally once a day (for both pediatric and adult dose)
Hepatic impairment: dose reduced to 7.5mg once daily followed by 5mg as a single dose.
Everotas is in tablet form. It should be administered orally at the same time every day.
Everotas should be taken with or without food.
Everotas tablets should not crush or broken.
CONTRAINDICATION
Everotas 5mg is contraindicated to sirolimus and other rapamycin derivatives, to produce anaphylactic reactions.PREGNANCY
Everotas 5mg should not use in pregnancy conditions and for breastfeeding mothers.Pregnancy category: C
Everotas 5mg causes harm or any malformation in unborn babies.
STORAGE
Everotas 5mg should be stored in room temperatureKeep away from moisture, heat, and light
MISSED DOSE
In the case of the missed dose, patients must consult with medical practitioner and follow the instructions given by them.On the other hand, the missed dose should be avoiding and follow the regular dosing schedule.
Comments
Post a Comment